Retinopathy of prematurity: Incidence, severity and outcome;Retinopatía del prematuro: Incidencia, gravedad y evolución

Anales de Pediatria

Volumn 58, Issue 2, 2003, Pages 156-161

  Martin Begue N ^a   Perapoch Lopez J ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Loss of vision; Prematurity; Retinopathy of prematurity

Indexed keywords

CORTICOSTEROID; SURFACTANT;

ANEMIA; ARTICLE; BIRTH WEIGHT; BRAIN HEMORRHAGE; CHORIOAMNIONITIS; CORTICOSTEROID THERAPY; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; GESTATIONAL AGE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN JAUNDICE; NEWBORN SCREENING; NEWBORN SEPSIS; OXYGEN THERAPY; PREMATURITY; PROSPECTIVE STUDY; RETROLENTAL FIBROPLASIA; RISK FACTOR;

EID: 0038407589     PISSN: 16954033     EISSN: None     Source Type: Journal    
DOI: 10.1157/13042980     Document Type: Article

References (29)

1. Holmstrom G, Broberger U, Thomassen P. Neonatal risk factors for retinopathy of prematurity -a population - based study. Acta Ophthalmol Scand 1998;76:204-7.
2. Olea JL, Corretger FJ, Salvat M, Frau E, Galiana C, Fiol M. Factores de riesgo en la retinopatia del prematuro. An Esp Pediatr 1997;47:172-6.
3. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of criotherapy for retinopathy of prematurity: Preliminary results. Arch Ophthalmol 1988;106:471-9.
4. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of criotherapy for retinopathy of prematurity: Three-month outcome. Arch Ophthalmol 1990;108:195-204.
5. Pearce IA, Pennie FC, Gannon LM, Weindling AM, Clark DI. Three year visual outcome for treated stage 3 retinopathy of prematurity: Cryotherapy versus laser. Br J Ophthalmol 1998;82:1254-9.
6. Fleck BW. Therapy for retinopathy of prematurity. Lancet 1999;353:166-7.
7. DeJonge MH, Ferrone PJ, Trese MT. Diodo laser ablation for threshold retinopathy of prematurity. Arch Ophthalmol 2000;118:365-7.
8. Committe for the Classification of Retinopathy of Prematurity: The International Classification of Retinopathy of Prematurity. Arch Ophthalmol 1984;102:1130-4.
9. The International Committee for the Classification of the Late Stages of Retinopathy of Prematurity. An International Classification of Retinopathy of Prematurity: The classification of retinal detachment. Arch Ophthalmol 1987;105:906-12.
10. Lim J, Fong DS, Dang Y. Decreased prevalence of retinopathy of prematurity in an inner-city hospital. Ophthalmic Surg Lasers 1999;30:12-6.
11. Termote J, Schalij-Delfos NE, Brouwers HAA, Donders ART, Cats BP. New developments in neonatology: Less severe retinopathy of prematurity. J Pediatr Ophthalmol Strabismus 2000;37:142-8.
12. Bossi E, Koerner F. Retinopathy of prematurity. Intensive Care Med 1995;21:241-6.
13. Pallás CR, Tejada P, Medina MC, Martin MJ, Orbea C, Barrios MC. Retinopatía del prematuro: nuestra experiencia. An Esp Pediatr 1995;42:52-6.
14. Holmstrom G, El Azazi M, Jacobson L, Lennerstrand G. A population based, prospective study of the development of ROP in prematurely born children in the Stockholm area of Sweden. Br J Ophthalmol 1993;77:417-23.
15. Palmer EA, Flynn JT, Hardy RJ, Phelps DL, Phillips CL, Schaffer DB, et al. Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology 1991;98:1628-40.
16. aJ, Sánchez R, Barreiro JC, Canete R, Fernández F, Zapatero M, et al. Retinopatia del prematuro. Resultados tras un año de seguimiento. An Esp Pediatr 1996;44:482-4.
17. Ng YK, Shaw DE, Fielder AR, Levene MI. Epidemiology of retinopathy of prematurity. Lancet 1988;26:1235-8.
18. Repka MX, Palmer EA, Tung B. Involution of retinopathy of prematurity. Arch Ophthalmol 2000;118:645-9.
19. De la Cruz Bértolo Fj, Pallás Alonso CR, Tejada Palacios P. Cribado para la retinopatía de la prematuridad: ni son todos los que están, ni están todos los que son. An Esp Pediatr 1999;50:156-60.
20. Lee SK, Normand C, McMillan D, Ohlsson A, Vincer M, Lyons C. Evidence for changing guidelines for routine screening for retinopathy of prematurity. Arch Pediatr Adolesc Med 2001;155:387-95.
21. The Royal College of Ophthalmologists British Association of Perinatal Medicine. Rethinopathy of prematurity: Guidelines for screening and treatment. London, England: Royal College of Ophthalmologists British Association of Perinatal Medicine, 1995.
22. American Academy of Pediatrics, the American Association for Pediatric Ophthalmology and Strabismus, and the American Academy of Ophthalmology. Screening examination of premature infants for retinopathy of prematurity. Ophthalmology 1997;104:888-9.
23. Nissenkorn I, Kremer I, Gilad E. "Rush" type retinopathy of prematurity, report of three cases. Br J Ophthalmol 1987;71:559-62.
24. Saugstad OD. Oxygen radical disease in neonatology. Semin Neonatol 1998;3:229-38.
25. Kinsey VE, Jacobs JT, Hemphill FM. Retrolental fibroplasia: Cooperative study of retrolental fibroplasia and the use of oxygen. Arch Ophthalmol 1956;56:481-547.
26. The STOP-ROP Multicenter Study Group. Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial. I: Primary outcomes. Pediatrics 2000;105:295-310.
27. Gu X, Samuel S, El-Shabrawey M, Caldwell RB, Bartoli M, Marcus DM, et al. Effects of sustained hyperoxia on revascularization in experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci 2002;43:496-502.
28. Holmstrom G, El Azazi M, Kugelberg U. Ophthalmological long term follow up of preterm infants: A population based, prospective study of the refraction and its development. Br J Ophthalmol 1998;82:1265-71.
29. Ricci B. Refractive errors and ocular motility disorders in preterm babies with and without retinopathy of prematurity. Ophthalmologica 1999;213:295-9.